February 28, 2015 1:23 PM ET

Pharmaceuticals

Company Overview of MedImmune, LLC

Executive Profile

Scott P. Carmer

Chief Executive Officer of Orgenesis Maryland Inc., Orgenesis Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 4 different industries.

See Board Relationships
49$104,167
As of Fiscal Year 2014

Background

Mr. Scott P. Carmer has been Chief Executive Officer of Orgenesis Maryland Inc. a subsidiary of Orgenesis Inc. since July 23, 2014. Mr. Carmer served as the Chairman of the Board and an Executive Vice President of Commercial Operations at MedImmune, LLC. Mr. Carmer served as an Executive Vice President of Commercial Operations at MedImmune Limited since August 2010. He served as Vice President of Sales and Marketing at Rituxan Immunology at Genentech Inc. since April ...

Corporate Headquarters

One MedImmune Way
Gaithersburg, Maryland 20878

United States

Phone: 301-398-0000
Fax: 301-527-4200

Board Members Memberships

Director

Education

BS
University of Kentucky

Other Affiliations

Annual Compensation

Salary$104,167
Total Annual Compensation$104,167

Stocks Options

Unexercisable Options$1,641,300
Total Number of Options$1,641,300

Total Compensation

Total Annual Cash Compensation$104,167
Total Short Term Compensation$104,167
Total Calculated Compensation$104,167
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MedImmune, LLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.